ESC 365 - Patients experiences with generic drugs following early post-discharge after first-time percutaneous coronary intervention

ACNAP Premium Access

Patients experiences with generic drugs following early post-discharge after first-time percutaneous coronary intervention

Session: Poster Session 2 - Acute Coronary Syndromes - Treatment

Topic: Pharmacotherapy

Speaker: Professor T. Norekval (Bergen, NO)

Event: EuroHeartCare 2019

Congress Presentation

Add to my library

About the speaker

Professor Tone Merete Norekval

Haukeland University Hospital, Bergen (Norway)

3 presentations

0 follower

6 more presentations in this session

Treatment of acute hyperglycemia: evaluation of a Yale protocol adapted for patients with acute coronary syndrome (YALE-ACS)

Speaker: Mr M. Mazza (Milan, IT)

Coronary artery ectasia, an independent predictor of high thrombus burden in patients presenting with ST-elevation myocardial infarction

Speaker: Mr K. Kintis (Athens, GR)

Thrombus aspiration in combination with glycoprotein IIb/IIIa inhibitors with or without stent implantation in patients presenting with STEMI and high thrombus burden

Speaker: Mr K. Kintis (Athens, GR)

Can we use HbA1c as a biomarker for predicting the short-term outcome after acute myocardial infarction?

Speaker: Doctor M. El Tahlawi (Zagazig, EG)

Llong-term natural course and clinical outcomes of coronary spasm

Speaker: Doctor M. Lee (Seoul, KR)

Access the full session

Poster Session 2 - Acute Coronary Syndromes - Treatment

Speakers: Professor T. Norekval, Mr M. Mazza, Mr K. Kintis, Mr K. Kintis, Doctor M. El Tahlawi...

About the event

EuroHeartCare 2019

2 May - 4 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources